These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1639540)

  • 1. The effect of schedule, protein binding and growth factors on the activity of suramin.
    Lopez Lopez R; Peters GJ; van Loenen AC; Pizao PE; van Rijswijk RE; Wagstaff J; Pinedo HM
    Int J Cancer; 1992 Jul; 51(6):921-6. PubMed ID: 1639540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
    Kraft A; Reid LM; Zvibel I
    Cancer Res; 1993 Feb; 53(3):652-7. PubMed ID: 8381048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of suramin on adenylate cyclase and protein kinase C.
    Lopez-Lopez R; Langeveld CH; Pizao PE; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
    Anticancer Drug Des; 1994 Aug; 9(4):279-90. PubMed ID: 7916897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostates.
    Mitchen J; Rago R; Wilding G
    Prostate; 1993; 22(1):75-89. PubMed ID: 7678932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures.
    Gansler T; Vaghmar N; Olson JJ; Graham SD
    J Urol; 1992 Sep; 148(3):910-4. PubMed ID: 1512858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.
    Fujiuchi S; Ohsaki Y; Kikuchi K
    Oncology; 1997; 54(2):134-40. PubMed ID: 9075785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suramin activity in human head and neck squamous cell carcinoma cell lines].
    Li AT
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):108-9, 125. PubMed ID: 8217281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
    Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
    Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.
    Kim JH; Sherwood ER; Sutkowski DM; Lee C; Kozlowski JM
    J Urol; 1991 Jul; 146(1):171-6. PubMed ID: 2056586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of purified alpha-fetoprotein and growth factors on the proliferation of porcine granulosa cells in monolayer culture.
    Keel BA; Eddy KB; Cho S; May JV
    Endocrinology; 1991 Jul; 129(1):217-25. PubMed ID: 1711460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine secretion of a colorectum-derived growth factor by HT-29 human colon carcinoma cell line.
    Culouscou JM; Garrouste F; Remacle-Bonnet M; Bettetini D; Marvaldi J; Pommier G
    Int J Cancer; 1988 Dec; 42(6):895-901. PubMed ID: 3263953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3.
    Ewing MW; Liu SC; Gnarra JR; Walther MM; Meyers CE; Linehan WM
    Cancer; 1993 Feb; 71(3 Suppl):1151-8. PubMed ID: 8428338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium.
    Fantini J; Verrier B; Robert C; Pic P; Pichon J; Mauchamp J; Marvaldi J
    Exp Cell Res; 1990 Jul; 189(1):109-17. PubMed ID: 2161345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of suramin on cell proliferation of various types of human malignant cells].
    Bai LY; Miyazaki M; Namba M
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):387-91. PubMed ID: 1848419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of suramin on human lung cancer cell line in vitro].
    Fujiuchi S; Tsuji T; Ohsaki Y; Kikuchi K
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):647-52. PubMed ID: 8154891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
    Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
    Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.